Announcements
Updated Journal Policies and Manuscript Template Adjustment
2025 Template Updates
- Journal Title : Pharmacology, Medical Reports, Orthopedic, and Illness Details
- Abbreviation : Pharmacol. Med. Rep. Orthop. Illn. Det.
- Initials : COMORBID
- Frequency : January, April, July, October
- Online ISSN : 2809-9745
- Editor in Chief : Dr. Nicholas Chally Tirayoh
- Managing Editor : Dewi Anggraini
- DOI : 10.55047/comorbid by Crossref
- Focus and Scope : see focus and scope here
- Type of Review : Double Blind Review
- Publisher : Transpublika Publisher
- Contact : +62811231666
- E-mail : jurnalcomorbid@gmail.com
- Citation Analysis : Dimensions | Google Scholar | Garuda
Pharmacology, Medical Reports, Orthopedic, and Illness Details (COMORBID) is an open-access, double-blind peer-reviewed scientific journal published by Transpublika Publisher. The focus and scope publishes research on all aspects of medicine, from fundamental research to major clinical trials and cost-effectiveness analyses. It generally publishes human research that contributes to the understanding of medical epidemiology, etiology, and physiology; the development of prognostic and diagnostic technologies; clinical trials that evaluate the efficacy of particular therapies, including comparative trials; and systematic reviews. The purpose of publishing this journal is to encourage the translation of fundamental research into clinical trials and of clinical evidence into therapeutic practice, for an audience that includes the international medical community, educators, policymakers, and patient advocacy groups. Article types include original research articles, review articles, conceptual and theoretical papers, case reports and case studies, and methodological studies.
COMORBID journal was first published in 2022 and is published four times a year, in January, April, July, and October. The journal holds the e-ISSN 2809-9745, and each article is assigned a DOI through Crossref. COMORBID is committed to publishing high-quality articles by ensuring double-blind peer review, plagiarism screening, adherence to publication ethics and editorial policies, and academic writing standards set out in the author guidelines. The journal is indexed in Sinta, Crossref, Dimensions, Google Scholar, Scilit, and GARUDA, among others.
COMORBID is also maintains institutional collaborations with higher education institutions, namely Universitas Islam Malang (Unisma). Through this collaboration, COMORBID is confident it will make a significant contribution to advancing medical science and its translation into clinical practice, particularly in the fields of pharmacology, medical case reporting, and orthopedics.
e-ISSN 2809-9745
Pharmacology, Medical Reports, Orthopedic, and Illness Details (COMORBID) is an open-access, double-blind peer-reviewed scientific journal published by Transpublika Publisher. The focus and scope publishes research on all aspects of medicine, from fundamental research to major clinical trials and cost-effectiveness analyses. It generally publishes human research that contributes to the understanding of medical epidemiology, etiology, and physiology; the development of prognostic and diagnostic technologies; clinical trials that evaluate the efficacy of particular therapies, including comparative trials; and systematic reviews. The purpose of publishing this journal is to encourage the translation of fundamental research into clinical trials and of clinical evidence into therapeutic practice, for an audience that includes the international medical community, educators, policymakers, and patient advocacy groups. Article types include original research articles, review articles, conceptual and theoretical papers, case reports and case studies, and methodological studies.
COMORBID journal was first published in 2022 and is published four times a year, in January, April, July, and October. The journal holds the e-ISSN 2809-9745, and each article is assigned a DOI through Crossref. COMORBID is committed to publishing high-quality articles by ensuring double-blind peer review, plagiarism screening, adherence to publication ethics and editorial policies, and academic writing standards set out in the author guidelines. The journal is indexed in Sinta, Crossref, Dimensions, Google Scholar, Scilit, and GARUDA, among others.
COMORBID is also maintains institutional collaborations with higher education institutions, namely Universitas Islam Malang (Unisma). Through this collaboration, COMORBID is confident it will make a significant contribution to advancing medical science and its translation into clinical practice, particularly in the fields of pharmacology, medical case reporting, and orthopedics.
e-ISSN 2809-9745
Announcement of Updated Manuscript Template and Author Guidelines for Volume 6
2026-11-11Dear Authors, Reviewers, and Readers,
PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) is pleased to announce an updated manuscript template, effective from Volume 6, Issue 1. This follows our earlier announcement on Updated Journal Policies, which aims to improve the quality of the journal.
2025 Template Updates
2024-11-02
Vol. 5 No. 3 (2026): JULY
Published: 2026-06-10
In this issue Vol. 5 No. 3 (2026): July, we have processed 8 submitted manuscripts. 2 articles were declined after initial review by the editor, 1 article was declined after the peer review process, and 5 articles were published.
In this issue Vol. 5 No. 3 (2026): July, all of the published articles were authored/co-authored by 26 authors, from 13 Institutions, and 3 Countries, i.e., Universitas Tarumanagara (Indonesia), K.R.M.T. Wongsonegoro Regional General Hospital (Indonesia), Universitas Airlangga (Indonesia), Dr. Soetomo General Academic Hospital (Indonesia), Universitas Maarif Hasyim Latif (Indonesia), National Hospital Abuja (Nigeria), Baze University Abuja (Nigeria), Federal University Lafia (Nigeria), Medical Laboratory Science Council of Nigeria (Nigeria), Plateau State University Bokkos (Nigeria), University of Jos (Nigeria), Cleveland Clinic (United States), and Federal University Wukari (Nigeria).










(

















